Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer
Frontiers in Oncology · 30.07.2026 · 16
DOI: 10.3389/fonc.2026.1902166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 30.07.2026. Verfasst von Qiao-Liang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To develop a delta radiomics model based on 18F-FDG PET/CT to predict prognosis after NAT for LAPC. Materials and methods This study retrospectively collected data from 33 patients with LAPC admitted to our hospital from August 2019 to July 2024. The volume of the regions of interests (VOIs) of LAPC lesions was outlined on 18F-FDG PET/CT images before and after neoadjuvant therapy. Radiomics features were extracted based on the VOIs, and the subtraction of the two radiomics features was the delta radiomics feature. Feature screening was performed using t-test and LASSO-COX regression to build a prediction model. ROC curves were used to assess the predictive ability of the prediction model for progression-free survival (PFS). Calibration curve and decision curve analysis (DCA) were used to assess the accuracy and net benefit of the prediction model, respectively.
Results
Univariate Cox regression analysis demonstrated that neither clinical parameters nor 18F-FDG PET/CT metabolic parameters were independent factors in predicting PFS in LAPC. A predictive model was constructed based on two delta radiomics features screened by LASSO-COX regression. The delta radiomics model demonstrated a high predictive ability for PFS with a C-index of 0.78 (95%CI: 0.68-0.88). High-risk patients identified by delta features showed markedly shorter PFS (HR:5.357, P = 0.006). DCA indicated favorable clinical utility for the delta radiomics model.
Conclusion
The delta radiomics model based on 18F-FDG PET/CT, provides a non-invasive tool to predict prognosis in LAPC after NAT, which may facilitate personalized treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Hepatopancreatobiliary Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- The Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Zitieren
APA
Chen, Q. L., Yang, L. X., Li, A. M., Mao, L., Qiu, Y. D., Du, J., & He, J. (2026). Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1902166
Vancouver
Chen QL, Yang LX, Li AM, Mao L, Qiu YD, Du J, et al. Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1902166
BibTeX
@article{Chen2026,
author = {Chen, Qiao-Liang and Yang, Ling-Xiao and Li, Ai-Mei and Mao, Liang and Qiu, Yu-Dong and Du, Juan and He, Jian},
title = {Predictive value of 18F-FDG PET/CT delta radiomics model for prognosis after neoadjuvant therapy for locally advanced pancreatic cancer},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1902166}
}
EUVIMED